المؤلفون: Lof P; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Soolingen NJ; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Piek JMJ; Department of Obstetrics and Gynecology, Catharina Hospital, Catharina Cancer Institute, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands., Aarts JWM; Department of Obstetrics and Gynecology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Retèl VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Health Technology and Services Research, University of Twente, Hallenweg 5, 7522 NH Enschede, The Netherlands., Bukman M; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, 3062 PA Rotterdam, The Netherlands., Smorenburg CH; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van Driel WJ; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Amant F; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Gynecologic Oncology, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium., Trum JW; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Lok CAR; Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: c.lok@nki.nl.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 227-234. Date of Electronic Publication: 2024 May 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/surgery , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/psychology , Cytoreduction Surgical Procedures*/methods , Patient Preference*/statistics & numerical data, Humans ; Female ; Aged ; Middle Aged ; Surveys and Questionnaires ; Adult ; Aged, 80 and over ; Neoplasm Staging ; Decision Making ; Carcinoma, Ovarian Epithelial/surgery ; Carcinoma, Ovarian Epithelial/mortality ; Carcinoma, Ovarian Epithelial/pathology

المؤلفون: van der Zanden V; University Medical Center Groningen, University of Groningen, Department of Internal Medicine, Hanzeplein 1, 9713GZ Groningen, the Netherlands. Electronic address: v.van.der.zanden@umcg.nl., van Soolingen NJ; The Netherlands Cancer Institute, Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Viddeleer AR; University Medical Center Groningen, University of Groningen, Department of Radiology, Medical Imaging Center, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Trum JW; The Netherlands Cancer Institute, Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Amant F; The Netherlands Cancer Institute, Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; KU Leuven, Department of Oncology, Herestraat 49, 3000 Leuven, Belgium., Mourits MJE; University Medical Center Groningen, University of Groningen, Department of Gynecological Oncology, Hanzeplein 1, 9713GZ Groningen, the Netherlands., Portielje JEA; Leiden University Medical Center, Leiden University, Department of Medical Oncology, Albinusdreef 2, 2333ZA Leiden, the Netherlands., Baalbergen A; Reinier de Graaf Group, Department of Obstetrics and Gynecology, Reinier de Graafweg 5, 2625AD Delft, the Netherlands., Souwer ETD; Leiden University Medical Center, Leiden University, Department of Medical Oncology, Albinusdreef 2, 2333ZA Leiden, the Netherlands., van Munster BC; University Medical Center Groningen, University of Groningen, Department of Internal Medicine, Hanzeplein 1, 9713GZ Groningen, the Netherlands. Electronic address: b.c.van.munster@umcg.nl.

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2022 Apr; Vol. 48 (4), pp. 896-902. Date of Electronic Publication: 2021 Oct 22.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoadjuvant Therapy*/methods , Ovarian Neoplasms*/complications , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/surgery, Aged ; Aged, 80 and over ; Carcinoma, Ovarian Epithelial/surgery ; Chemotherapy, Adjuvant/methods ; Cytoreduction Surgical Procedures/methods ; Female ; Humans ; Muscle, Skeletal/diagnostic imaging ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Retrospective Studies

المؤلفون: van der Zanden V; University Medical Center Groningen, University of Groningen, Department of Internal Medicine, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands. Electronic address: v.van.der.zanden@umcg.nl., van Soolingen NJ; The Netherlands Cancer Institute, Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Viddeleer AR; University Medical Center Groningen, University of Groningen, Department of Radiology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands., Trum JW; The Netherlands Cancer Institute, Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Amant F; The Netherlands Cancer Institute, Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; KU Leuven, Department of Oncology, Herestraat 49, 3000 Leuven, Belgium., Mourits MJE; University Medical Center Groningen, University of Groningen, Department of Gynecological Oncology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands., Portielje JEA; Leiden University Medical Center, Leiden University, Department of Medical Oncology, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands., van den Bos F; Leiden University Medical Center, Leiden University, Department of Medical Oncology, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands., de Kroon CD; Leiden University Medical Center, Leiden University, Department of Obstetrics and Gynecology, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands., Kagie MJ; Haaglanden Medical Center, Department of Obstetrics and Gynecology, Lijnbaan 32, 2512 VA, The Hague, the Netherlands., Oei SA; Haaglanden Medical Center, Department of Radiology, Lijnbaan 32, 2512 VA, The Hague, the Netherlands., Baalbergen A; Reinier de Graaf Group, Department of Obstetrics and Gynecology, Reinier de Graafweg 5, 2625 AD, Delft, the Netherlands., van Haaften-de Jong ALD; Haga Medical Center, Department of Obstetrics and Gynecology, Els Borst-Eilersplein 275, 2545 AA, The Hague, the Netherlands., Houtsma D; Haga Medical Center, Department of Medical Oncology, Els Borst-Eilersplein 275, 2545 AA, The Hague, the Netherlands., van Munster BC; University Medical Center Groningen, University of Groningen, Department of Internal Medicine, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands. Electronic address: b.c.van.munster@umcg.nl., Souwer ETD; Leiden University Medical Center, Leiden University, Department of Medical Oncology, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.

المصدر: Gynecologic oncology [Gynecol Oncol] 2021 Aug; Vol. 162 (2), pp. 360-367. Date of Electronic Publication: 2021 Jun 07.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cytoreduction Surgical Procedures/*adverse effects , Ovarian Neoplasms/*surgery , Postoperative Complications/*epidemiology , Sarcopenia/*epidemiology, Aged ; Aged, 80 and over ; Female ; Humans ; Length of Stay ; Muscle, Skeletal/diagnostic imaging ; Neoplasm Staging ; Ovarian Neoplasms/complications ; Ovarian Neoplasms/diagnosis ; Postoperative Complications/etiology ; Preoperative Period ; Retrospective Studies ; Risk Assessment/statistics & numerical data ; Risk Factors ; Sarcopenia/diagnosis ; Sarcopenia/etiology ; Tomography, X-Ray Computed/statistics & numerical data

المؤلفون: van Soolingen NJ; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. l.v.soolingen@nki.nl., Smorenburg CH; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Hamaker ME; Department of Geriatric Medicine, Diakonessenhuis Utrecht, Bosboomstraat 1, 3582 KE, Utrecht, The Netherlands., Groen WG; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Retèl VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Health Technology and Services Research (HTSR), University of Twente, Hallenweg 5, 7522 NH, Enschede, The Netherlands., Lok CAR; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van de Poll-Franse LV; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; CoRPS - Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Warandelaan 2, 5037 AB, Tilburg, The Netherlands.; The Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands., Trum JW; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

المصدر: Trials [Trials] 2020 Feb 22; Vol. 21 (1), pp. 214. Date of Electronic Publication: 2020 Feb 22.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Geriatric Assessment* , Nutritional Status* , Quality of Life*, Carcinoma, Ovarian Epithelial/*therapy , Ovarian Neoplasms/*therapy, Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cost-Benefit Analysis ; Cytoreduction Surgical Procedures ; Female ; Frail Elderly ; Humans ; Multicenter Studies as Topic ; Netherlands ; Pragmatic Clinical Trials as Topic

المؤلفون: van Walree IC; Department of Internal Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands ivwalree@diakhuis.nl., van Soolingen NJ; Department of Gynecologic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hamaker ME; Department of Geriatric Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Smorenburg CH; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Louwers JA; Department of Gynecology, Diakonessenhuis Utrecht, Utrecht, The Netherlands., van Huis-Tanja LH; Department of Internal Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2019 Jan; Vol. 29 (1), pp. 158-165.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Decision Making* , Quality of Life*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Cystadenocarcinoma, Serous/*therapy , Cytoreduction Surgical Procedures/*methods , Ovarian Neoplasms/*therapy, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Case-Control Studies ; Combined Modality Therapy ; Cystadenocarcinoma, Serous/pathology ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Ovarian Neoplasms/pathology ; Prognosis ; Retrospective Studies ; Survival Rate